Skip to main content
. 2019 Jun 13;20:353. doi: 10.1186/s13063-019-3452-y

Fig. 1.

Fig. 1

Flowchart overview of the trial design. IV intravenous, MRSA methicillin-resistant Staphylococcus aureus, MSSA methicillin-susceptible Staphylococcus aureus, SIRS systemic inflammatory response syndrome. SPIRIT checklist (2013) provided in Additional file 2